WAEPS - Monthly Scientific MeetingsPresented jointly with the University of Washington Department of Ophthalmology Join your colleagues for a monthly learning session presented by top experts in a variety of ophthalmology sub-specialties. The Monthly Scientific Meeting series is available to members throughout the state via webinar. Be sure to register online on the WAEPS website and you will automatically receive an email with login instructions the day before the lecture. Please check your junk box for the email confirmation as many webinar links tend to be considered spam. In-Person program (when in Phase 3) is held at the 7th Floor Conference Room in the 9th and Jefferson Building (908 Jefferson St.) in Seattle from 6:30 p.m. to 8:30 p.m. Or contact the WAEPS office: waeps@waeps.org
WAEPS members may self-register online for each month’s program using the link at the bottom of this page. Your automatic confirmation email will contain the webinar login information for that month’s session. If you need assistance with registration or do not receive your confirmation, please contact the WAEPS office no later than 3 p.m. on the day of the session you plan to participate in. At the bottom of this page you will find an Archive of all past meeting for review by WAEPS members. UPCOMING MONTHLY MEETINGS:December 16, 2020 Steven S. Saraf, MD Assistant Professor Dept. of Ophthalmology University of Washington Seattle, WA
Disclosures: Dr. Saraf has no ACCME defined commercial interests. His presentation will be evidence based and free of bias. Lecture 1. The Choroid: The Final Frontier Learning objectives: After participating in this activity, attendees should be able to: 1.Identify conditions in retina and uveitis where extended evaluation of the choroid may be of clinical utility.
2. Interpret the testing modalities used to assess the choroid, including enhanced depth imaging optical coherence tomography (OCT), indocyanine angiography, OCT angiography, and choroidal vascularity index (CVI).
3. Describe the features of pachycormid spectrum disorders.
4. Utilize testing modalities to assess choroidal neovascularization and distinguish subclinical choroidal neovascularization from clinically active choroidal neovascularization.
Lecture 2. Ocular Complications of Novel Cancer Therapies
Learning objectives:
After participating in this activity, attendees should be able to: 1. Understand the mechanism of action of novel cancer therapies (immunotherapy, targeted therapy) and the impact of these agents on systemic health and patient survival.
2.Recall characteristic manifestations of novel cancer therapies when adversely affecting the eye.
3. Identify strategies to manage ocular side effects while maximizing systemic benefit for patients on these agents.
Register OnlineJanuary 20, 2021 Mark Rosenblatt, MD, PhD, MBA, MHA
Executive Dean of the College of Medicine
Department of Ophthalmology
University of Illinois
Disclosures: Dr. Rosenblatt has disclosed the following relationships with ACCME defined commercial interests:
Learning objectives: After participating in this activity, attendees should be able to: 1. Identify new tissue engineering therapeutics to treat corneal disease
2.Learn how surgeons obtain their cadaveric corneal tissue
Learning objectives: After participating in this activity, attendees should be able to: 1. Assessment and care of dry eye patients
2. Identify disorders of the corneal nerves that have many consequences including dry eye disease.
3. Understand that corneal nerves are essential to the health of the ocular surface
Department of Ophthalmology
University of Miami School of Medicine
Miami, Florida
Disclosures: Dr. Gedde has no ACCME defined commercial interests. His presentation will be evidence based and free of bias.
Learning objectives:
After participating in this activity, attendees should be able to:
1.Discuss the indications of incisional glaucoma surgery
2.Identify traditional glaucoma procedures used in the surgical management of glaucoma
3.Discribe newer procedures classified in minimal invasive glaucoma surgery (MIGS).
Learning objectives:
After participating in this activity, attendees should be able to:
1.Discribe the study designs of several multicenter randomized clinical trails in glaucoma
2.Discuss the major findings of recent clinical trials on glaucoma
3. Apply results of glaucoma clinical trials to patient care.
Register OnlineMarch 17, 2021 Professor of Neurology Disclosures: Dr. Trobe has no ACCME defined commercial interests. His presentation will be evidence based and free of bias. Lecture 1: Tips and Traps in the Evaluation of Diplopia (part 1) Learning objectives: After participating in this activity, attendees should be able to: 1. Know the common mistakes in evaluating diplopia
2. Know how to deploy the diagnostic tools in evaluating diplopia
Learning objectives: After participating in this activity, attendees should be able to:
Register Online April 21, 2021 University of California
San Francisco, CA
Disclosures: Dr. Vagefi has disclosed the following relationships with ACCME defined commercial interests:
Lecture 1: Freeze the Squeeze: Update on Blepharospasm Learning objectives: After participating in this activity, attendees should be able to: 1.Understand the clinical presentation of blepharospasm
2.Apply concepts in disease mechanism of blepharospasm
3 Describe current treatment options for blepharospasm.
Learning objectives: After participating in this activity, attendees should be able to: 1. Discuss the mechanisms of pain in a blind eye
2. Understand an escalating treatment paradigm for a blind painful eye
3. Assess the efficacy of different treatment modalities for a blind painful eye
Associate Professor
Harvard Medical School
Boston, MA
Disclosures: Dr. Pierce has disclosed the following relationships with ACCME defined commercial interests:
Lecture 1: Genetics of Inherited Retinal Degenerations Learning objectives: After participating in this activity, attendees should be able to: 1. Have a better understanding of the genetic causality of inherited retinal degenerations.
Lecture 2: Clinical Translation of Genetic Therapies for Inherited Retinal Degenerations Learning objectives: After participating in this activity, attendees should be able to: 1.Be educated and informed regarding clinical use of genetic therapies for inherited retinal degenerations Register Online
_______________________________Please find our past Monthly Scientific Meetings archived here for your review.
View Monthly Meeting Archive(Requires Member Login) Credit for the series is an exclusive WAEPS member benefit and free of charge. Members in good standing of neighboring states' ophthalmology societies may also be eligible. Check with the WAEPS office for details. Attention California Ophthalmologists: If you are registering from California, please contact your Society Executive VP Craig Kliger ([email protected]) to register. Do not register via the WAEPS online tool. If you participated in a previous year's series and have a question about your CME credit, please contact Kimberly Conn, WAEPS Executive Director: [email protected] or phone: 206-956-3652. Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Washington School of Medicine and Washington Academy of Eye Physicians and Surgeons. The University of Washington School of Medicine is accredited by the ACCME to provide continuing medical education for physicians The University of Washington School of Medicine designates this live activity for a maximum of 16.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 2.0 credits) Planning Committee Disclosures: To view an archive of past Monthly WAEPS Scientific Meetings, please click here. Please note, you must be logged in to access the archive page. |